TechNation Radio Podcast Episode 15-42 The World of Consumer Tech Innovation
Oct 21, 2015
59:00
On this week’s Tech Nation, Moira speaks with GARY SHAPIRO, the long-time President of the Consumer Electronics Association, about what’s happening with technology innovation in the United States and worldwide.
Then on BioTech Nation, it’s all about using viruses and bacteria to deliver treatments for everything from Ebola to rare juvenile diseases from Sanfilippo and Batten disease to Fanconi Anemia.
Our first guest is DR. RIPLEY BALLOU, Head, of Clinical Research and Translational Science at GSK (Glaxo Smith Kline) about what brought us the 2014 Ebola crisis and their race to find a vaccine.
Then we speak with DR. TIM MILLER, President & CEO, Abeona Therapeutics about their work to find gene therapies to treat two rare and deadly diseases classified as lysosomal storage disorders: Sanfilippo type A and type B and juvenile Batten disease. They are also working on another genetic disorder, Fanconi Anemia, using a CRISPR/Cas 9 system to replace defective DNA with the correct sequence.
We finish this episode with DAVID WILLIAMS, Managing Director, Bactevo about their new drug discovery process that uses bacteria. He explains how they are modifying bacteria to create new medicines using new technologies such as DNA sequencing, nano-microfluidic technologies, and artificial intelligence algorithms.
Then on BioTech Nation, it’s all about using viruses and bacteria to deliver treatments for everything from Ebola to rare juvenile diseases from Sanfilippo and Batten disease to Fanconi Anemia.
Our first guest is DR. RIPLEY BALLOU, Head, of Clinical Research and Translational Science at GSK (Glaxo Smith Kline) about what brought us the 2014 Ebola crisis and their race to find a vaccine.
Then we speak with DR. TIM MILLER, President & CEO, Abeona Therapeutics about their work to find gene therapies to treat two rare and deadly diseases classified as lysosomal storage disorders: Sanfilippo type A and type B and juvenile Batten disease. They are also working on another genetic disorder, Fanconi Anemia, using a CRISPR/Cas 9 system to replace defective DNA with the correct sequence.
We finish this episode with DAVID WILLIAMS, Managing Director, Bactevo about their new drug discovery process that uses bacteria. He explains how they are modifying bacteria to create new medicines using new technologies such as DNA sequencing, nano-microfluidic technologies, and artificial intelligence algorithms.